Blonanserin



Indications and Reactions:

Role Indications Reactions
Secondary
Schizophrenia 30.6%
Insomnia 15.7%
Drug Use For Unknown Indication 10.9%
Epilepsy 8.1%
Schizophrenia, Disorganised Type 7.7%
Product Used For Unknown Indication 5.2%
Akathisia 3.2%
Delusion 3.2%
Hallucination 3.2%
Constipation 2.8%
Parkinsonism 2.8%
Psychotic Disorder 2.4%
Anxiety 1.6%
Dermatitis Allergic 1.2%
Prophylaxis 0.8%
Depressive Symptom 0.4%
Neuroleptic Malignant Syndrome 17.5%
Rhabdomyolysis 15.0%
Urinary Retention 12.5%
Parkinsonism 10.0%
Blood Lactate Dehydrogenase Increased 7.5%
Constipation 7.5%
Acute Hepatic Failure 5.0%
Bradykinesia 5.0%
Neurological Symptom 5.0%
Renal Failure Acute 5.0%
Overdose 2.5%
Somnolence 2.5%
Stupor 2.5%
Suicide Attempt 2.5%
Concomitant
Schizophrenia 37.0%
Constipation 12.6%
Schizophrenia, Paranoid Type 12.0%
Autonomic Nervous System Imbalance 5.6%
Foetal Exposure During Pregnancy 5.6%
Product Used For Unknown Indication 4.8%
Insomnia 4.5%
Schizophrenia, Disorganised Type 2.9%
Bipolar Ii Disorder 2.7%
Vomiting 2.3%
Parkinsonism 2.1%
Crohn's Disease 1.7%
Dementia With Lewy Bodies 1.2%
Dermatitis 0.8%
Nasopharyngitis 0.8%
Smoking Cessation Therapy 0.8%
Threatened Labour 0.8%
Epilepsy 0.6%
Gastritis 0.6%
Hypotension 0.6%
Tremor 12.7%
Agitation 8.9%
Pyrexia 7.6%
Tri-iodothyronine Decreased 7.6%
Urinary Retention 7.6%
Off Label Use 5.1%
Pneumonia 5.1%
Psychotic Disorder 5.1%
White Blood Cell Count Increased 5.1%
Condition Aggravated 3.8%
Feeding Disorder Neonatal 3.8%
Ileus Paralytic 3.8%
Pancytopenia 3.8%
Parkinsonism 3.8%
Schizophrenia 3.8%
Aspartate Aminotransferase Increased 2.5%
Depression Suicidal 2.5%
Dermatitis 2.5%
Electrocardiogram Qt Prolonged 2.5%
Feeding Disorder 2.5%